Data Foundry

Medical device recalls 2019

Discovery NM/CT 670 CZT — Class II medical device recall Z-1258-2019

Terminated recall by GE Healthcare, LLC, reported 2019-05-08. During installation of certain Nuclear Medicine systems delivered with dismounted detectors, some detector scr

Recall numberZ-1258-2019
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmGE Healthcare, LLC, Waukesha, WI, United States
Recall initiated2019-03-20
Classified2019-05-02
Reported by FDA2019-05-08
Terminated2020-10-05
Countries outside the USAT, CA, CH, DE, ES, FR, GB, HR, IN, IT, JP, KR, NL, PL, PT, SE, SK, ZA
Quantity3 units
Model numbersH3906CT

Product

Discovery NM/CT 670 CZT, Model/Catalogue/Code H3906CT Product Usage: The GE Discovery NM/CT 670 CZT system is intended for general Nuclear Medicine imaging procedures for detection of radioisotope tracer uptake in the patient body. It includes a general purpose Nuclear Medicine system using a variety of scanning modes supported by various acquisition types, and a Computed Tomography system which is intended for enabling attenuation correction and anatomical localization of SPECT images and for standalone head, whole body, cardiac and vascular X-ray Computed Tomography applications.

Reason for recall

During installation of certain Nuclear Medicine systems delivered with dismounted detectors, some detector screws may not have been secured correctly, leading to the possible loss of one detector mounting design redundancy.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1258-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.